Related Experiment Video
Updated: May 10, 2026

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites
Published on: March 22, 2016
BET proteins promote efficient murine leukemia virus integration at transcription start sites
Amit Sharma1, Ross C Larue, Matthew R Plumb
1Center for Retrovirus Research, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
Abstract:
The selection of chromosomal targets for retroviral integration varies markedly, tracking with the genus of the retrovirus, suggestive of targeting by binding to cellular factors. γ-Retroviral murine leukemia virus (MLV) DNA integration into the host genome is favored at transcription start sites, but the underlying mechanism for this preference is unknown. Here, we have identified bromodomain and extraterminal domain (BET) proteins (Brd2, -3, -4) as cellular-binding partners of MLV integrase. We show that purified recombinant Brd4(1-720) binds with high affinity to MLV integrase and stimulates correct concerted integration in vitro. JQ-1, a small molecule that selectively inhibits interactions of BET proteins with modified histone sites impaired MLV but not HIV-1 integration in infected cells. Comparison of the distribution of BET protein-binding sites analyzed using ChIP-Seq data and MLV-integration sites revealed significant positive correlations. Antagonism of BET proteins, via JQ-1 treatment or RNA interference, reduced MLV-integration frequencies at transcription start sites. These findings elucidate the importance of BET proteins for MLV integration efficiency and targeting and provide a route to developing safer MLV-based vectors for human gene therapy.
Insights
Bromodomain and extraterminal domain (BET) proteins bind to Moloney murine leukemia virus (MLV) integrase, promoting its integration into the host genome. Inhibiting BET proteins reduces MLV integration at transcription start sites, suggesting a new therapeutic target.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- Retroviral DNA integration into the host genome is a critical step in viral replication and gene therapy vector design.
- Murine leukemia virus (MLV) preferentially integrates near transcription start sites, but the mechanism remains unclear.
Purpose of the Study:
- To identify cellular factors involved in MLV integration targeting.
- To elucidate the mechanism of MLV integration site selection.
- To explore potential therapeutic strategies for safer MLV-based vectors.
Main Methods:
- Co-immunoprecipitation and in vitro binding assays to identify MLV integrase interacting proteins.
- Biochemical assays to assess the effect of BET proteins on MLV integration.
- ChIP-sequencing to map BET protein binding sites.
- Inhibition studies using JQ-1 small molecule and RNA interference to assess the role of BET proteins in MLV integration.
Main Results:
- Bromodomain and extraterminal domain (BET) proteins (Brd2, -3, -4) were identified as binding partners of MLV integrase.
- Recombinant Brd4 protein binds MLV integrase and enhances in vitro integration.
- The BET inhibitor JQ-1 impaired MLV integration in infected cells.
- Significant positive correlation was observed between BET protein binding sites and MLV integration sites.
- Antagonism of BET proteins reduced MLV integration frequency at transcription start sites.
Conclusions:
- BET proteins are crucial for the efficiency and targeting of MLV integration.
- BET proteins play a significant role in directing MLV DNA to transcription start sites.
- Targeting BET proteins offers a potential strategy for developing safer MLV-based gene therapy vectors.
More Related Videos
10:10Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
Published on: May 28, 2017
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Leaky Scanning
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...